Myotec Therapeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Merger of Eq.

Myotec Therapeutics General Information

Description

Developer of novel therapeutics for the treatment of cancer and other clinically unmet diseases. The company develops drugs for the treatment of cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 154B Milton Park
  • Abingdon OX14 4SD
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 154B Milton Park
  • Abingdon OX14 4SD
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Myotec Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger of Equals 15-Dec-2010 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 08-Mar-2010 00.000 00.000 000.00 Completed Startup
1. Seed Round Completed Startup
To view Myotec Therapeutics’s complete valuation and funding history, request access »

Myotec Therapeutics Executive Team (1)

Name Title Board Seat
Stefan Anker Ph.D Scientific Founder
To view Myotec Therapeutics’s complete executive team members history, request access »

Myotec Therapeutics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invesco Asset Management Asset Manager Minority 000 0000 000000 0
Touchstone Innovations Venture Capital Minority 000 0000 000000 0
To view Myotec Therapeutics’s complete investors history, request access »

Myotec Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Akamis Bio 01-Jan-2010 000000 00 Drug Discovery
To view Myotec Therapeutics’s complete acquisitions history, request access »

Myotec Therapeutics FAQs

  • When was Myotec Therapeutics founded?

    Myotec Therapeutics was founded in 2006.

  • Who is the founder of Myotec Therapeutics?

    Stefan Anker Ph.D is the founder of Myotec Therapeutics.

  • Where is Myotec Therapeutics headquartered?

    Myotec Therapeutics is headquartered in Abingdon, United Kingdom.

  • What industry is Myotec Therapeutics in?

    Myotec Therapeutics’s primary industry is Biotechnology.

  • Is Myotec Therapeutics a private or public company?

    Myotec Therapeutics is a Private company.

  • What is Myotec Therapeutics’s current revenue?

    The current revenue for Myotec Therapeutics is 000000.

  • How much funding has Myotec Therapeutics raised over time?

    Myotec Therapeutics has raised $8.61M.

  • Who are Myotec Therapeutics’s investors?

    Invesco Asset Management and Touchstone Innovations have invested in Myotec Therapeutics.

  • When was Myotec Therapeutics acquired?

    Myotec Therapeutics was acquired on 15-Dec-2010.

  • Who acquired Myotec Therapeutics?

    Myotec Therapeutics was acquired by Akamis Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »